Contribution of Reduced and Oxidized Glutathione to Signals Detected by Magnetic Resonance Spectroscopy As Indicators of Local Brain Redox State
Overview
Authors
Affiliations
The reduced form of glutathione (GSH; gamma-glutamyl cysteinyl glycine) is supposedly the most powerful reducing battery in the central nervous system against oxidative stress. We evaluated the contribution of GSH and GSSG to MEGA-PRESS (a frequency-selective refocusing technique) signals assessed by magnetic resonance spectroscopy (MRS). GSH gave a single positive signal (2.95 ppm) by the MEGA-PRESS. In contrast, GSSG gave a multiplet of reversed signals (3.03, 3.23, and 3.34 ppm). A phantom solution mimicking the normal in vivo condition (GSH:GSSG=100:1) gave a single positive peak. Even when the ratio was changed to 10:1, corresponding to toxic oxidative stress, GSH was prominent and GSSG signals were minimal. Thus, GSSG signals could be negligible. In the phantom solution (creatine:GSH:aspartate:gamma-aminobutyric acid=7:3:1:1), the creatine signal overshadowed the other signals. Through the MEGA-PRESS, a single peak of GSH stood out over other signals. In vivo, the brains of healthy volunteers gave similar signals as the in vitro phantom solution, indicating that the signal originated from GSH. The estimated concentration of GSH in the human brain was 1.9+/-0.37 mM (mean+/-S.D., n=4). In conclusion, MEGA-PRESS allowed us to assess GSH levels in vivo non-invasively.
Choi G, Kim S, Noeske R, Moore J, Lee G, Kim J NMR Biomed. 2025; 38(2):e5313.
PMID: 39776150 PMC: 11707642. DOI: 10.1002/nbm.5313.
Frontal and occipital brain glutathione levels are unchanged in autistic adults.
Pereira A, Leonard A, Velthuis H, Wong N, Ponteduro F, Dimitrov M PLoS One. 2024; 19(8):e0308792.
PMID: 39146282 PMC: 11326623. DOI: 10.1371/journal.pone.0308792.
Prefrontal Glutathione Levels in Major Depressive Disorder Are Linked to a Lack of Positive Affect.
OGorman Tuura R, Buchmann A, Ritter C, Hase A, Haynes M, Noeske R Brain Sci. 2023; 13(10).
PMID: 37891842 PMC: 10605149. DOI: 10.3390/brainsci13101475.
A Phase 1 Study of Oral Vitamin D in Boys and Young Men With X-Linked Adrenoleukodystrophy.
Van Haren K, Cunanan K, Awani A, Gu M, Pena D, Chromik L Neurol Genet. 2023; 9(2):e200061.
PMID: 37090939 PMC: 10117697. DOI: 10.1212/NXG.0000000000200061.
The Potential Use of Ebselen in Treatment-Resistant Depression.
Ramli F, Cowen P, Godlewska B Pharmaceuticals (Basel). 2022; 15(4).
PMID: 35455482 PMC: 9030939. DOI: 10.3390/ph15040485.